Treatment for diabetes
Patent Number: 6558952
Date of First Priority Issue: Thursday July 30th, 1998
Date Issued: Tuesday May 6th, 2003
Assignee: Waratah Pharmaceuticals, Inc. (Quebec, CA); The General Hospital Corporation (Boston, MA)
Inventors: Parikh, Indu (Chapel Hill, NC); Lane, Anne (Westmount, CA); Nardi, Ronald V. (Mahwah, NJ); Brand, Stephen J. (Lincoln, MA)
From Class: Use
Comments: No comments
This patent teaches how to induce endogenous islet stem cells to multiply through administration of gastrin together with a ligand of the EGF receptor such as TGF alpha. One of the principles behind the current company doing clinical trials with this, Dr Tony Cruz, is also involved in the company Stem Cell Therapeutics, which is performing clinical trials with exogenous agents that stimulate endogenous neural stem cells for the treatment of stroke.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.